Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group-Reference-Cited by-同舟云学术

Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group

Published:2007-08-09 Issue:11 Volume:21 Page:2258-2263
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tomizawa D,Koh K,Sato T,Kinukawa N,Morimoto A,Isoyama K,Kosaka Y,Oda T,Oda M,Hayashi Y,Eguchi M,Horibe K,Nakahata T,Mizutani S,Ishii E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404903.pdf

Reference30 articles.

1. Pui C-H, Evans WE . Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166–178.

2. Dördelmann M, Reiter A, Borkhardt A, Ludwig W-D, Götz N, Viehmann S et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209–1217.

3. Ferster A, Benoit Y, Francotte N, Dresse M-F, Uyttebroeck A, Plouvier E et al. Treatment outcome in infant acute lymphoblastic leukemia. Blood 2000; 95: 2729–2731.

4. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999; 17: 445–455.

5. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 2006; 108: 441–451.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of infants with very late relapse of acute lymphoblastic leukaemia initially treated in Interfant‐06;British Journal of Haematology;2024-07-09

2. Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors;Expert Review of Hematology;2024-06-25

3. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors;Cell Transplantation;2024-01

4. Indications for Transplantation of ALL from a Pediatric Perspective;Japanese Journal of Transplantation and Cellular Therapy;2024

5. The Core Complex of Yeast COMPASS and Human Mixed-Lineage Leukemia (MLL), Structure, Function, and Recognition of the Nucleosome;Subcellular Biochemistry;2024